Diurnal variations in endocrine and psychological responses to 0.2 mg/kg naloxone administration in patients with major depressive disorder and matched controls
- 1 January 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of Affective Disorders
- Vol. 57 (1-3) , 37-47
- https://doi.org/10.1016/s0165-0327(99)00070-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Hypothalamo-pituitary-adrenal axis abnormalities in depression: a review and a modelPsychological Medicine, 1989
- Pituitary and Adrenocortical Responses to the Ovine Corticotropin Releasing Hormone in Depressed Patients and Healthy VolunteersArchives of General Psychiatry, 1987
- High-Dose Naloxone Infusions in NormalsArchives of General Psychiatry, 1983
- OPIATE MODULATION OF THE PITUITARY‐ADRENAL AXIS: EFFECTS OF STRESS AND CIRCADIAN RHYTHMClinical Endocrinology, 1982
- Direct Inhibitory Effect of Glucocorticoids upon Testicular Luteinizing Hormone Receptor and Steroidogenesisin Vivoandin Vitro*Endocrinology, 1981
- NEUROTRANSMITTER STUDIES OF NEUROENDOCRINE PATHOLOGY IN DEPRESSIONActa Psychiatrica Scandinavica, 1980
- Naloxone decreases diurnal variation in pain sensitivity and somatosensory evoked potentialsLife Sciences, 1978
- Neuroendocrine Regulation in DepressionArchives of General Psychiatry, 1976
- PEPTIDE TRANSMITTERS: A UNIFYING HYPOTHESIS FOR EUPHORIA, RESPIRATION, SLEEP, AND THE ACTION OF LITHIUMThe Lancet, 1976
- Clinical antidepressant activity of cyclazocine—a narcotic antagonistClinical Pharmacology & Therapeutics, 1970